Key result
Sustained VT linked to ~6-fold higher in-hospital mortality in ST-segment elevation acute coronary syndrome.
Why the study?
Studies often assess severe ventricular arrhythmias without evaluating sustained ventricular tachycardia separately, and epidemiological data on this complication were lacking in Algeria.
Observational (n=467)
No
Hazard Ratio: 6 (95% CI 1.7–21)
Absolute Event Rate: 17.64% vs 3.11%
p-value: p=0.005
Sustained ventricular tachycardia occurs in 3.6% of STEMI patients and is associated with a 6-fold increased risk of early hospital mortality, driven by hemodynamic instability and severe coronary lesions.
Sustained VT may warrant intensified monitoring in STEMI; leaves open whether targeted interventions improve survival.
Background: Sustained Ventricular Tachycardia is the most serious complication; in acute coronary syndrome with ST segment elevation, several international studies have reported incidence and predictive factors of severe ventricular arrhythmias, without identifying sustained ventricular tachycardia separately; also, its epidemiological data is lacking in Algeria. Aims: The main objective of our study is the determination of the frequency of sustained ventricular tachycardia in acute coronary syndrome with ST segment elevation, the secondary objective was the analysis of predictive factors of this arrhythmia, and related mortality. Methods and materials: In this prospective study, conducted in the cardiology department of Hussein Dey hospital (Algiers-Algeria), 467 patients with acute coronary syndrome with elevated ST segment (87 women and 380 men) were enrolled between 28 February 2014 and 16 July 2015. The average age is 60 ± 13 years; at admission, a Holter recorder was attached for continuous ECG monitoring during 48 hours Kruskal’s ANNOVA or H tests were used for comparison of quantitative variables, χ2 test or Fisher’s exact test, were used for qualitative variables, all tests were performed with 1st species risk of 5%. Results: The frequency of Sustained Ventricular Tachycardia is 3.6 % (17 patients), CI 95%: [1.9%-5.3%], multivariate analysis identified the following independent predictors: low diastolic blood pressure, severe coronary artery lesions, Elevated high sensitive troponin concentrations more than 5ng/ml. The risk of mortality expressed by Hazard Ration (HR) is 6. (CI95%: [1.7-21], p = 0.005); the predictors of mortality are: occurrence of ventricular fibrillation and low diastolic blood pressure. Conclusion: Sustained Ventricular tachycardia is the most serious complication during acute coronary syndrome with elevated ST segment, its predictive factors according to our study are: low diastolic blood pressure, severe coronary lesions, Elevated high sensitive troponin concentrations more than 5ng/ml, its occurrence increases the risk of hospital mortality.
No takes yet. Share an insight, caveat, or question.
Hanane ZOUZOU (2023) conducted an observational in Acute coronary syndrome with ST segment elevation (n=467). Sustained Ventricular Tachycardia vs. No Sustained Ventricular Tachycardia was evaluated on Hospital mortality (first 48 hours) (HR 6, 95% CI 1.7-21, p=0.005). Sustained ventricular tachycardia occurred in 3.6% of patients with ST-segment elevation acute coronary syndrome and was associated with a significantly increased risk of hospital mortality (HR 6).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: